CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE – a multi-centre experience in Italy-Reference-Cited by-同舟云学术

CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE – a multi-centre experience in Italy

Published:2023-07 Issue:1 Volume:62 Page:106817
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Gentile Ivan^ORCID,Buonomo Antonio Riccardo,Corcione Silvia,Paradiso Laurenza,Giacobbe Daniele Roberto^ORCID,Bavaro Davide Fiore,Tiseo Giusy^ORCID,Sordella Francesca,Bartoletti Michele,Palmiero Giulia,Vozza Antonietta,Vena Antonio,Canta Francesca,Moriello Nicola Schiano,Congera Paola^ORCID,Karruli Arta^ORCID,Tascini Carlo,Viale Pierluigi,Bono Valerio Del^ORCID,Falcone Marco,Carbonara Sergio,Mikulska Malgorzata Karolina,Bassetti Matteo,Durante-Mangoni Emanuele^ORCID,De Rosa Francesco Giuseppe^ORCID,Maraolo Alberto Enrico^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference41 articles.

1. Possible clinical indications of ceftobiprole;Barberan;Rev Esp Quimioter,2019

2. Ceftobiprole: drug evaluation and place in therapy;Giacobbe;Expert Rev Anti Infect Ther,2019

3. Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia;Syed;Drugs,2014

4. Ceftobiprole: a clinical view;Martínez Pérez-Crespo;Rev Esp Quimioter,2021

5. Real-life experience with ceftobiprole in a tertiary-care hospital;Durante-Mangoni;J Glob Antimicrob Resist,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How is ceftobiprole used in Canada: the CLEAR study final results;Expert Review of Anti-infective Therapy;2024-07-15

2. Ceftobiprole mono-therapy versus combination or non-combination regimen of standard antibiotics for the treatment of complicated infections: A systematic review and meta-analysis;Diagnostic Microbiology and Infectious Disease;2024-07

3. Role of tcaA, a potential target as a ceftobiprole resistance breaker in MRSA β-lactam resistance;International Journal of Antimicrobial Agents;2024-07

4. Real-World Experience of Ceftobiprole for Community- and Hospital-Acquired Pneumonia from a Stewardship Perspective;Microorganisms;2024-04-03

5. The Positioning of Ceftobiprole in the Treatment of Staphylococcus aureus Bacteremia;Clinical Infectious Diseases;2024-03-11